4//SEC Filing
OLUKOTUN ADEOYE Y 4
Accession 0001209191-21-055966
CIK 0000879407other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 5:25 PM ET
Size
6.9 KB
Accession
0001209191-21-055966
Insider Transaction Report
Form 4
OLUKOTUN ADEOYE Y
Director
Transactions
- Sale
Common Stock
2021-09-13$63.76/sh−2,750$175,340→ 9,000 total - Sale
Common Stock
2021-09-13$63.76/sh−2,250$143,460→ 11,750 total
Footnotes (2)
- [F1]Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001242615
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 5:25 PM ET
- Size
- 6.9 KB